SPONSOR

University of Texas Southwestern Medical Center

Total Trials

Recruiting

Phases

Phase 2, Phase 3, Phase 1, Phase 2, Phase 1

Conditions studied: HIV Pre-exposure Prophylaxis PrEP Laryngeal Carcinoma Multiple Sclerosis Eating Disorders Anorexia Nervosa Bulimia Nervosa Atypical Anorexia Nervosa Purging (Eating Disorders)Other Specified Feeding or Eating Disorder

University of Texas Southwestern Medical Center is a clinical research sponsor with 27 registered studies on ClinicalTrials.gov, of which 27 are actively recruiting participants. Research covers conditions including HIV Pre-exposure Prophylaxis, PrEP, Laryngeal Carcinoma, Multiple Sclerosis.

The trial portfolio spans Phase 2, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Texas Southwestern Medical Center

How many clinical trials has University of Texas Southwestern Medical Center sponsored?

ClinicalMetric currently tracks 27 clinical trials sponsored by University of Texas Southwestern Medical Center, of which 27 are actively recruiting participants. These trials cover conditions including HIV Pre-exposure Prophylaxis, PrEP, Laryngeal Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Texas Southwestern Medical Center research focus on?

University of Texas Southwestern Medical Center clinical trials span HIV Pre-exposure Prophylaxis, PrEP, Laryngeal Carcinoma, Multiple Sclerosis, Eating Disorders, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Texas Southwestern Medical Center clinical trial?

To participate in a University of Texas Southwestern Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Texas Southwestern Medical Center trials with current recruitment status updated daily.

University of Texas Southwestern Medical Center

Frequently Asked Questions — University of Texas Southwestern Medical Center

Clinical Trials by University of Texas Southwestern Medical Center

HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study

Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

NARCOMS Registry: A Multiple Sclerosis Registry

Targeting Social Function in Anxiety and Eating Disorders

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

A Polypill for Acute Coronary Syndrome

HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients

The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity

Monitoring System for Cranial Orthoses

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

Action Regulation Behavioral

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

MTOR Inhibitors in Older Adults

Dallas 2K: A Natural History Study of Depression

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Laryngeal Cryotherapy for Refractory Neurogenic Cough

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

ET Stigma Response to Tremor Suppression